Telangana becomes a reality as the 29th state of India, capping the decades-old struggle in the region for carving out a separate state from Andhra Pradesh. President’s rule imposed in united Andhra Pradesh would be revoked partially to facilitate the swearing-in of TRS government in the newly-created Telangana headed by K Chandrasekhar Rao. Governor ESL … Read more
A 14-year old girl from Andhra Pradesh has become the youngest woman to climb Mount Everest, the highest peak in the world. Poorna is from the Nizamabad district of Andhra Pradesh. On the unique mission, she was accompanied by Anand, who is from the Khammam district. Poorna and Anand symbolically carried photographs of BR Ambedkar … Read more
The largely unnoticed collision of the global epidemics of HIV and tuberculosis (TB) has exploded to create a deadly co-epidemic that is rapidly spreading in sub-Saharan Africa. However, health systems cannot adequately diagnose, treat, or contain the co-epidemic due to unanswered scientific and medical questions, according to a report issued today by The Forum for Collaborative HIV Research and amplified by experts from leading global health organizations.
On the heels of the fourth International AIDS Society?s Conference on HIV Pathogenesis, Treatment and Prevention, which took place in Sydney in late July, AIDS Healthcare Foundation (AHF) welcomed yesterday?s news that the FDA has approved Pfizer Inc.?s new AIDS salvage therapy, Selzentry (maraviroc), a different class of new antiretroviral AIDS drug which had been discussed and presented at the IAS conference.
The rise in the number of Australian HIV cases in the past seven years is likely to be related to risky sexual behaviour in men having sex with men, according to work co-authored by UNSW researchers.
Tibotec Pharmaceuticals Ltd. announced that it has submitted an application for marketing authorisation for TMC125 to the European Agency for the Evaluation of Medicinal Products (EMEA).
The International AIDS Society (IAS) convened and facilitated a meeting between Act Up-Paris and Abbott in Sydney, Australia.
With HIV infection driving a deadly resurgence of tuberculosis (TB), a new publication provides up-to-date recommendations for clinicians facing the many challenges of treating patients with both of these two complex diseases.
TMC125 (etravirine, ETR), Tibotec’s investigational next-generation non-nucleoside reverse transcriptase inhibitor (NNRTI), demonstrated significant efficacy in patients with NNRTI resistance, according to the 24-week primary endpoint analysis from two ongoing, phase III studies published in the 7 July, 2007, issue of The Lancet.
Imminent arrival of latest HIV drug darunavir, when combined with FUZEON, will give treatment-experienced patients a better chance to achieve undetectable viral load.